CD23-bound IgE augments and dominates recall responses through human naive B cells

Journal of Immunology

Volumn 186, Issue 2, 2011, Pages 1060-1067

  Griffith, Qyana K ^a   Liang, YanMei ^a   Onguru, Daniel O ^b   Mwinzi, Pauline N ^b   Ganley Leal, Lisa M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTIBODY; BREAKPOINT CLUSTER REGION PROTEIN; CD23 ANTIGEN; IMMUNOGLOBULIN E; PRAZIQUANTEL;

ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; CROSS LINKING; DOWN REGULATION; HELMINTH; HUMAN; INTRACELLULAR SIGNALING; KENYA; MALE; PRIORITY JOURNAL; SCHISTOSOMA; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, HELMINTH; B-LYMPHOCYTE SUBSETS; BINDING SITES, ANTIBODY; CELL LINE, TUMOR; G0 PHASE; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN E; IMMUNOLOGIC MEMORY; INTRACELLULAR FLUID; LYMPHOCYTE ACTIVATION; MICE; MICE, 129 STRAIN; MICE, INBRED NZB; PROTEIN BINDING; RECEPTORS, IGE; SCHISTOSOMIASIS MANSONI;

EID: 79251562522     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002709     Document Type: Article

References (47)

1. Dunne, D. W., A. E. Butterworth, A. J. Fulford, H. C. Kariuki, J. G. Langley, J. H. Ouma, A. Capron, R. J. Pierce, and R. F. Sturrock. 1992. Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur. J. Immunol. 22: 1483-1494.
2. Dunne, D. W., A. E. Butterworth, A. J. Fulford, J. H. Ouma, and R. F. Sturrock. 1992. Human IgE responses to Schistosoma mansoni and resistance to reinfection. Mem. Inst. Oswaldo Cruz 87(Suppl. 4): 99-103.
3. Hagan, P., U. J. Blumenthal, M. Chaudri, B. M. Greenwood, R. J. Hayes, I. Hodgson, C. Kelly, M. Knight, A. J. Simpson, S. R. Smithers, et al. 1987. Resistance to reinfection with Schistosoma haematobium in Gambian children: analysis of their immune responses. Trans. R. Soc. Trop. Med. Hyg. 81: 938-946.
4. Rihet, P., C. E. Demeure, A. Bourgois, A. Prata, and A. J. Dessein. 1991. Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels. Eur. J. Immunol. 21: 2679-2686.
5. + B cell subset correlates with the development of resistance to Schistosoma mansoni reinfection in occupationally exposed adults who have undergone multiple treatments. J. Infect. Dis. 199: 272-279.
6. Delespesse, G., M. Sarfati, and R. Peleman. 1989. Influence of recombinant IL-4, IFN-α, and IFN-γ on the production of human IgE-binding factor (soluble CD23). J. Immunol. 142: 134-138.
7. Kilmon, M. A., R. Ghirlando, M. P. Strub, R. L. Beavil, H. J. Gould, and D. H. Conrad. 2001. Regulation of IgE production requires oligomerization of CD23. J. Immunol. 167: 3139-3145.
8. Fujiwara, H., H. Kikutani, S. Suematsu, T. Naka, K. Yoshida, K. Yoshida, T. Tanaka, M. Suemura, N. Matsumoto, S. Kojima, et al. 1994. The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient mice. Proc. Natl. Acad. Sci. USA 91: 6835-6839.
9. Pirron, U., T. Schlunck, J. C. Prinz, and E. P. Rieber. 1990. IgE-dependent antigen focusing by human B lymphocytes is mediated by the low-affinity receptor for IgE. Eur. J. Immunol. 20: 1547-1551.
10. + B cells. J. Immunol. 175: 1473-1482.
11. Hjelm, F., F. Carlsson, A. Getahun, and B. Heyman. 2006. Antibody-mediated regulation of the immune response. Scand. J. Immunol. 64: 177-184.
12. Payet-Jamroz, M., S. L. Helm, J. Wu, M. Kilmon, M. Fakher, A. Basalp, J. G. Tew, A. K. Szakal, N. Noben-Trauth, and D. H. Conrad. 2001. Suppression of IgE responses in CD23-transgenic animals is due to expression of CD23 on nonlymphoid cells. J. Immunol. 166: 4863-4869.
13. Lewis, G., E. Rapsomaniki, T. Bouriez, T. Crockford, H. Ferry, R. Rigby, T. Vyse, T. Lambe, and R. Cornall. 2004. Hyper IgE in New Zealand Black mice due to a dominant-negative CD23 mutation. Immunogenetics 56: 564-571.
14. Ford, J. W., J. L. Sturgill, and D. H. Conrad. 2009. 129/SvJ mice have mutated CD23 and hyper IgE. Cell. Immunol. 254: 124-134.
15. Karagiannis, S. N., J. K. Warrack, K. H. Jennings, P. R. Murdock, G. Christie, K. Moulder, B. J. Sutton, and H. J. Gould. 2001. Endocytosis and recycling of the complex between CD23 and HLA-DR in human B cells. Immunology 103: 319-331.
16. Luo, H. Y., H. Hofstetter, J. Banchereau, and G. Delespesse. 1991. Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation. J. Immunol. 146: 2122-2129.
17. Ganley-Leal, L. M., P. N. Mwinzi, C. B. Cetre-Sossah, J. Andove, A. W. Hightower, D. M. Karanja, D. G. Colley, and W. E. Secor. 2006. Correlation between eosinophils and protection against reinfection with Schistosoma mansoni and the effect of human immunodeficiency virus type 1 coinfection in humans. Infect. Immun. 74: 2169-2176.
18. Ganley-Leal, L. M., X. Liu, and L. M. Wetzler. 2006. Toll-like receptor 2-mediated human B cell differentiation. Clin. Immunol. 120: 272-284.
19. Sato, T., A. Konishi, S. Yasuno, J. Arai, M. Kamei, M. Bitoh, and T. Yamaguchi. 1997. A new method for studying the binding of human IgE to CD23 and the inhibition of this binding. J. Immunol. Methods 209: 59-66.
20. Irish, J. M., D. K. Czerwinski, G. P. Nolan, and R. Levy. 2006. Kinetics of B cell receptor signaling in human B cell subsets mapped by phosphospecific flow cytometry. J. Immunol. 177: 1581-1589.
21. Kijimoto-Ochiai, S. 2002. CD23 (the low-affinity IgE receptor) as a C-type lectin: a multidomain and multifunctional molecule. Cell. Mol. Life Sci. 59: 648-664.
22. Noronha, A. M., Y. Liang, J. T. Hetzel, H. Hasturk, A. Kantarci, A. Stucchi, Y. Zhang, B. S. Nikolajczyk, F. A. Farraye, and L. M. Ganley-Leal. 2009. Hyperactivated B cells in human inflammatory bowel disease. J. Leukoc. Biol. 86: 1007-1016.
23. Kurosaki, T., and S. Tsukada. 2000. BLNK: connecting Syk and Btk to calcium signals. Immunity 12: 1-5.
24. Claesson, L., D. Larhammar, L. Rask, and P. A. Peterson. 1983. cDNA clone for the human invariant γ chain of class II histocompatibility antigens and its implications for the protein structure. Proc. Natl. Acad. Sci. USA 80: 7395-7399.
25. Lamb, C. A., and P. Cresswell. 1992. Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes. J. Immunol. 148: 3478-3482.
26. Achatz-Straussberger, G., N. Zaborsky, S. Königsberger, S. Feichtner, S. Lenz, D. Peckl-Schmid, M. Lamers, and G. Achatz. 2009. Limited humoral immunoglobulin E memory influences serum immunoglobulin E levels in blood. Clin. Exp. Allergy 39: 1307-1313.
27. Butterworth, A. E., M. Capron, J. S. Cordingley, P. R. Dalton, D. W. Dunne, H. C. Kariuki, G. Kimani, D. Koech, M. Mugambi, J. H. Ouma, et al. 1985. Immunity after treatment of human schistosomiasis mansoni, II: Identification of resistant individuals, and analysis of their immune responses. Trans. R. Soc. Trop. Med. Hyg. 79: 393-408.
28. Kinet, J. P. 1999. The high-affinity IgE receptor (FcεRI): from physiology to pathology. Annu. Rev. Immunol. 17: 931-972.
29. de Andres, B., E. Rakasz, M. Hagen, M. L. McCormik, A. L. Mueller, D. Elliot, A. Metwali,M. Sandor, B. E. Britigan, J. V.Weinstock, and R. G. Lynch. 1997. Lack of Fc-ε receptors on murine eosinophils: implications for the functional significance of elevated IgE and eosinophils in parasitic infections. Blood 89: 3826-3836.
30. Soussi Gounni, A., B. Lamkhioued, K. Ochiai, Y. Tanaka, E. Delaporte, A. Capron, J.-P. Kinet, and M. Capron. 1994. High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature 367: 183-186.
31. Yazdanbakhsh, M., and D. L. Sacks. 2010. Why does immunity to parasites take so long to develop? Nat. Rev. Immunol. 10: 80-81.
32. Fulford, A. J., M. Webster, J. H. Ouma, G. Kimani, and D. W. Dunne. 1998. Puberty and age-related changes in susceptibility to schistosome infection. Parasitol. Today 14: 23-26.
33. Kurtis, J. D., J. F. Friedman, T. Leenstra, G. C. Langdon, H. W. Wu, D. L. Manalo, L. Su, M. Jiz, B. Jarilla, A. O. Pablo, et al. 2006. Pubertal development predicts resistance to infection and reinfection with Schistosoma japonicum. Clin. Infect. Dis. 42: 1692-1698.
34. Jiz, M., J. F. Friedman, T. Leenstra, B. Jarilla, A. Pablo, G. Langdon, S. Pond-Tor, H. W. Wu, D. Manalo, R. Olveda, et al. 2009. Immunoglobulin E (IgE) responses to paramyosin predict resistance to reinfection with Schistosoma japonicum and are attenuated by IgG4. Infect. Immun. 77: 2051-2058.
35. Abebe, F., P. I. Gaarder, B. Petros, and S. G. Gundersen. 2002. Differences in prevalence, intensity of infection and parasite-specific antibody levels do not predict different age-infection profiles. APMIS 110: 535-544.
36. Gryseels, B. 1994. Human resistance to Schistosoma infections: age or experience? Parasitol. Today (Regul. Ed.) 10: 380-384.
37. Black, C. L., M. L. Steinauer, P. N. Mwinzi, W. Evan Secor, D. M. Karanja, and D. G. Colley. 2009. Impact of intense, longitudinal retreatment with praziquantel on cure rates of schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya. Trop. Med. Int. Health 14: 450-457.
38. Karanja, D. M., A. W. Hightower, D. G. Colley, P. N. Mwinzi, K. Galil, J. Andove, and W. E. Secor. 2002. Resistance to reinfection with Schistosoma mansoni in occupationally exposed adults and effect of HIV-1 co-infection on susceptibility to schistosomiasis: a longitudinal study. Lancet 360: 592-596.
39. Thomas, P. G., M. R. Carter, A. A. Da'dara, T. M. DeSimone, and D. A. Harn. 2005. A helminth glycan induces APC maturation via alternative NF-κB activation independent of IκBα degradation. J. Immunol. 175: 2082-2090.
40. Erb, K. J. 2007. Helminths, allergic disorders and IgE-mediated immune responses: where do we stand? Eur. J. Immunol. 37: 1170-1173.
41. + B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni. J. Infect. Dis. 202: 399-405.
42. Perona-Wright, G., K. Mohrs, J. Taylor, C. Zaph, D. Artis, E. J. Pearce, and M. Mohrs. 2008. Cutting edge: helminth infection induces IgE in the absence of μ- or δ-chain expression. J. Immunol. 181: 6697-6701.
43. Liu, W., T. Meckel, P. Tolar, H. W. Sohn, and S. K. Pierce. 2010. Antigen affinity discrimination is an intrinsic function of the B cell receptor. J. Exp. Med. 207: 1095-1111.
44. Depoil, D., S. Fleire, B. L. Treanor, M. Weber, N. E. Harwood, K. L. Marchbank, V. L. Tybulewicz, and F. D. Batista. 2008. CD19 is essential for B cell activation by promoting B cell receptor-antigen microcluster formation in response to membrane-bound ligand. Nat. Immunol. 9: 63-72.
45. Mongini, P. K., M. A. Vilensky, P. F. Highet, and J. K. Inman. 1997. The affinity threshold for human B cell activation via the antigen receptor complex is reduced upon co-ligation of the antigen receptor with CD21 (CR2). J. Immunol. 159: 3782-3791.
46. Hodgkin, P. D., J. H. Lee, and A. B. Lyons. 1996. B cell differentiation and isotype switching is related to division cycle number. J. Exp. Med. 184: 277-281.
47. Caven, T. H., A. Shelburne, J. Sato, Y. Chan-Li, S. Becker, and D. H. Conrad. 2005. IL-21 dependent IgE production in human and mouse in vitro culture systems is cell density and cell division dependent and is augmented by IL-10. Cell. Immunol. 238: 123-134.